Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Convenience: Capsules Are Easier, But Easier Is Not Always Better Capsules are simpler
Clinical trial data and FDA labeling information indicate that gastrointestinal effects are dose-dependent and typically most pronounced during initial treatment or dose escalation
The cumulative amount of tirzepatide detected in the remaining 7 breast milk samples over the 28-day sampling window was equivalent to less than 0.02% of the maternal administered dose, with the last measurable concentrations occurring 5 days post-dose
Subtle changes in post-meal energy levels and hunger patterns might emerge
PMID 26096748
US$ 26.49
US$ 27.35
US$ 21.95
US$ 20.62
US$ 22.97
US$ 28.95
